Pepscan
Company

Last deal

$8.87M
Local Amount - EUR 7M

Amount

Series B

Stage

19.09.2006

Date

2

all rounds

$14.84M

Total amount

date founded

Financing round

General

About Company
Pepscan uses protein mimicry for drug R&D and peptide products.

Industry

Sector :

Subsector :

Also Known As

Pepscan

founded date

01.01.1999

Number of employees

Company Type

Non-profit

Last funding type

Series B

IPO status

Private

Description

Pepscan is an all-in-one partner in peptides, providing a range of custom peptide services, including peptide synthesis and modifications, high-throughput synthesis, and screening of peptide libraries. Its protein mimicry platform delivers binding insights, even in cases where other technologies fall short, allowing medical scientists to develop personalized anti-cancer vaccines from tumor-specific antigens uniquely identified in proteins expressed in tumor cells.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
JPT Peptide Techologies

JPT Peptide Techologies

JPT provides innovative peptide products and services for research projects in Immunology, Proteomics and Enzyme Profiling.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Berlin, Germany
AnaSpec

AnaSpec

AnaSpec is a leading provider of integrated proteomic and genomic solutions™ for worldwide life science research.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Manufacturing, Life Science

Location

Fremont, CA, USA
Peptides & Elephants

Peptides & Elephants

Peptides&Elephants is a biotech company that provides customized peptide arrays, pools, libraries and synthesis technology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

16761 Hennigsdorf, Germany
Akthelia

Akthelia

Akthelia develops novel antimicrobial therapeutics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Reykjavík, Iceland

total rounds

5

total raised

$508.21K
M&A Details
1

Acquired by

Biosynth Carbosynth

announced date

30.06.2022

Financials

Funding Rounds
2
2

Number of Funding Rounds

$14.84M

Money Raised

Their latest funding was raised on 19.09.2006. Their latest investor Wageningen Business Generator. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
19.09.2006
4
$8.87M
Local Amount - EUR 7M
08.07.2005
5
$5.97M
Local Amount - EUR 5M
PPM Oost NV

PPM Oost NV

PPM Oost NV is a Dutch venture capital firm investing in health, technology, and food industry businesses.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Finance

Location

Apeldoorn, Netherlands

count Of Investments

21

count Of Exists

7
Co-Investors
Investors
6
1

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series A, Series B

Wageningen Business Generator

Wageningen Business Generator B.V. provides research services and entrepreneurship workshops to Wageningen University and Research Centre.

Sector

Industrial Support Services

Subsector

Business Training and Employment Agencies

Keywords

Business Development

Location

Wageningen, Netherlands

count Of Investments

1

count Of Exists

1
MKB & Technofonds Flevoland

MKB & Technofonds Flevoland

MKB & Technofonds Flevoland is a corporate investor focusing on investing in startups in the biotechnology and life science industries.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Non-Profit, Financial Services, Biotechnology

Location

8244 AL Lelystad- Haven, Netherlands

count Of Investments

27

count Of Exists

2
PPM Oost NV

PPM Oost NV

PPM Oost NV is a Dutch venture capital firm investing in health, technology, and food industry businesses.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Finance

Location

Apeldoorn, Netherlands

count Of Investments

21

count Of Exists

7

People

Employee Profiles
7
Hans de Backer

Hans de Backer

CEO

Evert Van Dijk

Evert Van Dijk

Chief Commercial Officer

Rob Meloen

Founder

Jos Joore

Jos Joore

Team Member

Activity

Recent News
0